TARS Tarsus Pharmaceuticals, Inc. - Common Stock
$72,44
Prix · Aoû 19, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$48–$84
68% of range
Note des analystes
STRONG BUY
15 analysts
Objectif de cours
$95
+31% upside
P/E (TTM)
-46.1
ROE
-19.7%
Marge nette
-14.7%
TARS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$72.44
Capitalisation Boursière
$3.12B
P/E (TTM)
-46.1
BPA (TTM)
$-1.59
Revenus (TTM)
$451M
Rendement div.
—
ROE
-19.7%
Dette/Capitaux propres
0.2
Fourchette 52 semaines
$48 – $84
TARS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$451M
2020-12-31
→
2025-12-31
BPA
$-1.59
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-22M
2020-12-31
→
2025-12-31
Marges
-14.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
TARS
Médiane des pairs
P/E (TTM)
-46.1
29.4
P/S (TTM)
6.9
4.9
P/B
9.1
6.5
EV / EBITDA
-39.1
—
Price / FCF (Cours / FCF)
-139.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
TARS
Médiane des pairs
Operating Margin (Marge d'exploitation)
-15.7%
—
Net Profit Margin (Marge nette)
-14.7%
-9.0%
ROA
-14.1%
-8.2%
ROE
-19.7%
-19.4%
ROIC
-17.6%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
TARS
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
0.2
—
Current Ratio (Ratio de liquidité)
3.9
3.6
Quick Ratio (Ratio de liquidité réduite)
3.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
TARS
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
146.7%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
159.5%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
TARS
Médiane des pairs
TARS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 7 46,7%
- Achat 7 46,7%
- Conserver 1 6,7%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
7 analystes · 2026-08-19
Médiane
$99.00
Moyenne
$94.86
← En dessous de tous les objectifs
$72.44
Bas
$84.00
Haut
$104.00
Objectif médian
$99.00
+36,7%
Objectif moyen
$94.86
+30,9%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.49 | $-0.20 | -0.29% |
| 31 mars 2026 | $-0.16 | $-0.38 | 0.22% |
| 31 décembre 2025 | $-0.20 | $-0.10 | -0.10% |
| 30 septembre 2025 | $-0.30 | $-0.36 | 0.06% |
| 30 juin 2025 | $-0.48 | $-0.41 | -0.07% |
| 31 mars 2025 | $-0.64 | $-0.75 | 0.11% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M | $0 | |
| R&D Expense | $64M | $53M | $50M | $43M | $42M | $19M | |
| SG&A Expense | $427M | $237M | $109M | $45M | $25M | $8M | |
| Operating Expenses | $522M | $304M | $161M | $89M | $69M | $27M | |
| Operating Income | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M | |
| Interest Expense | · | · | $3M | $2M | $0 | · | |
| Other Non-op | $-202.0K | $-206.0K | $274.0K | $86.0K | $-73.0K | $0 | |
| Pretax Income | $-64M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Income Tax | $2M | $0 | $0 | $-4.0K | $55.0K | $1.0K | |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| EPS (Basic) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| Shares (Basic) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| Shares (Diluted) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| EBITDA | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M |
Bilan 26
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $95M | $225M | $72M | $171M | $168M | |
| Short-term Investments | $234M | $197M | $2M | $145M | $483.0K | $0 | |
| Receivables | $85M | $47M | $17M | $0 | $0 | $0 | |
| Inventory | $4M | $3M | $3M | $0 | · | · | |
| Prepaid Expense | $13M | $15M | $8M | $5M | $4M | $2M | |
| Current Assets | $523M | $357M | $256M | $225M | $176M | $171M | |
| PP&E (Net) | $12M | $2M | $1M | $957.0K | $755.0K | $548.0K | |
| PP&E (Gross) | $14M | $4M | $3M | $2M | $976.0K | $682.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $546.0K | $221.0K | $134.0K | |
| Intangibles | $7M | $8M | $4M | $0 | · | · | |
| Other Non-current Assets | $2M | $999.0K | $2M | $585.0K | $1M | $81.0K | |
| Total Assets | $562M | $377M | $265M | $228M | $179M | $172M | |
| Accounts Payable | $16M | $9M | · | · | · | · | |
| Current Liabilities | $136M | $81M | $37M | $15M | $11M | $5M | |
| Capital Leases | $11M | $0 | $2M | $52.0K | $585.0K | $549.0K | |
| Other Non-current Liabilities | $11M | $0 | $2M | $100.0K | $699.0K | $605.0K | |
| Total Liabilities | $219M | $152M | $69M | $35M | $12M | $6M | |
| Long-term Debt | $72M | $72M | $30M | $19M | · | · | |
| Total Debt | $72M | $72M | $30M | $19M | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $770M | $585M | $442M | $302M | $213M | $199M | |
| Retained Earnings | $-427M | $-360M | $-245M | $-109M | $-47M | $-33M | |
| AOCI | $381.0K | $179.0K | $-2.0K | $-74.0K | $0 | · | |
| Stockholders' Equity | $343M | $225M | $197M | $193M | $167M | $166M | |
| Liabilities + Equity | $562M | $377M | $265M | $228M | $179M | $172M | |
| Shares Outstanding | 42,553,931 | 38,349,826 | 34,211,190 | 26,727,458 | 20,698,737 | 20,323,201 |
Flux de trésorerie 12
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $42M | $28M | $20M | $13M | $8M | $839.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $961.0K | $540.0K | $133.0K | $0 | · | · | |
| Operating Cash Flow | $-12M | $-83M | $-117M | $-49M | $4M | $-21M | |
| CapEx | $10M | $2M | $2M | $506.0K | $586.0K | $456.0K | |
| Investing Cash Flow | $-42M | $-199M | $141M | $-145M | $-586.0K | $-456.0K | |
| Debt Issued | $0 | $75M | $10M | $20M | · | · | |
| Net Debt Issued | $0 | $75M | · | · | · | · | |
| Financing Cash Flow | $143M | $155M | $130M | $94M | $21.0K | $132M | |
| Net Change in Cash | $89M | $-128M | $153M | $-100M | $3M | $110M | |
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M | $-22M | |
| Levered FCF | · | · | $-122M | $-52M | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | · | |
| Pretax Margin | -14.3% | -63.2% | -778.9% | -240.5% | -24.1% | · | |
| EBITDA Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| ROA | -14.1% | -36.0% | -55.1% | -30.5% | -7.9% | -23.3% | |
| ROE | -19.7% | -50.0% | -66.2% | -31.4% | -8.0% | -36.2% | |
| ROIC | -17.6% | -40.7% | -63.1% | -29.5% | -7.3% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 | 31.7 | |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 | 31.2 | |
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | -42.8 | -28.5 | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.1 | 0.1 | 0.3 | · | |
| Receivables Turnover | 6.8 | 5.8 | 2.1 | · | · | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | 948.6% | -32.4% | -54.7% | · | · | |
| Revenue CAGR 3Y | 159.5% | 47.5% | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $183M | $17M | $26M | $57M | $0 | |
| Net Income TTM | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Market Cap | $3.48B | $2.12B | $693M | $392M | $466M | $840M | |
| Enterprise Value | $3.14B | $1.90B | $495M | $194M | · | · | |
| P/E | -51.5 | -18.0 | -4.4 | -5.8 | -33.6 | -9.6 | |
| P/S | 7.7 | 11.6 | 39.7 | 15.2 | 8.2 | · | |
| P/B | 10.1 | 9.5 | 3.5 | 2.0 | 2.8 | 5.1 | |
| P / Tangible Book | 10.4 | 9.8 | 3.6 | 2.0 | 2.8 | 5.1 | |
| P / Cash Flow | -279.8 | -25.6 | -5.9 | -8.0 | 124.3 | -39.7 | |
| P / FCF | -156.2 | -25.1 | -5.8 | -7.9 | 147.3 | -38.9 | |
| EV / EBITDA | -44.2 | -15.8 | -3.5 | -3.1 | · | · | |
| EV / FCF | -140.7 | -22.5 | -4.2 | -3.9 | · | · | |
| EV / Revenue | 7.0 | 10.4 | 28.4 | 7.5 | · | · | |
| Earnings Yield | -1.9% | -5.5% | -22.8% | -17.2% | -3.0% | -10.4% |
Compte de résultat 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $162M | $152M | $119M | $103M | $78M | $66M | $48M | $41M | $28M | $13M | $2M | $0 | $2M | $10M | $0 | |
| Cost of Revenue | $12M | $9M | · | · | $6M | $5M | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| R&D Expense | $31M | $22M | $18M | $16M | $16M | $14M | $17M | $12M | $12M | $12M | $13M | $12M | $13M | $12M | $10M | $11M | |
| SG&A Expense | $151M | $136M | $131M | $109M | $103M | $85M | $69M | $58M | $59M | $52M | $43M | $30M | $20M | $15M | $15M | $12M | |
| Operating Expenses | $194M | $168M | $160M | $133M | $125M | $105M | $91M | $73M | $74M | $65M | $58M | $43M | $33M | $27M | $25M | $23M | |
| Operating Income | $-20M | $-6M | $-8M | $-15M | $-22M | $-26M | $-24M | $-25M | $-33M | $-38M | $-44M | $-41M | $-33M | $-25M | $-15M | $-23M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $983.0K | · | $858.0K | $815.0K | $684.0K | · | $633.0K | |
| Other Non-op | $-281.0K | $-87.0K | $-74.0K | $98.0K | $-145.0K | $-81.0K | $-27.0K | $67.0K | $-65.0K | $-181.0K | $363.0K | $-48.0K | $-47.0K | $6.0K | $-50.0K | $-7.0K | |
| Income Tax | $3M | $2M | · | · | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-5.0K | |
| Net Income | $-19M | $-7M | $-8M | $-13M | $-20M | $-25M | $-23M | $-23M | $-33M | $-36M | $-42M | $-39M | $-31M | $-23M | $-14M | $-23M | |
| EPS (Basic) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| EPS (Diluted) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| Shares (Basic) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| Shares (Diluted) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| EBITDA | $-20M | $-6M | · | $-15M | $-22M | $-26M | · | $-25M | $-33M | $-38M | · | $-41M | $-33M | $-25M | · | $-23M |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $102M | $184M | $113M | $97M | $176M | $95M | $176M | $181M | $194M | · | $227M | $107M | $66M | · | $169M | |
| Short-term Investments | $245M | $287M | $234M | $289M | $284M | $232M | $197M | $141M | $142M | $105M | · | $20M | $71M | $135M | · | $57M | |
| Receivables | $96M | $100M | $85M | $73M | $58M | $62M | $47M | $29M | $30M | $30M | · | $5M | · | $2M | · | $17.0K | |
| Inventory | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $4M | · | $15.0K | · | · | · | · | |
| Prepaid Expense | $10M | $27M | $13M | $22M | $29M | $6M | $15M | $7M | $6M | $7M | · | $6M | $5M | $5M | · | $3M | |
| Current Assets | $562M | $537M | $523M | $502M | $474M | $481M | $357M | $357M | $363M | $341M | · | $259M | $183M | $209M | · | $234M | |
| PP&E (Net) | $20M | $18M | $12M | $6M | $3M | $3M | $2M | $2M | $2M | $1M | · | $2M | $2M | $1M | · | $951.0K | |
| PP&E (Gross) | $22M | $20M | $14M | $8M | $6M | $5M | $4M | $4M | $4M | $3M | · | $3M | $2M | $2M | · | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $832.0K | $649.0K | · | $448.0K | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $4M | $4M | · | $4M | · | · | · | · | |
| Other Non-current Assets | $660.0K | $715.0K | $2M | $1M | $1M | $616.0K | $999.0K | $888.0K | $846.0K | $1M | · | $1M | $1M | $529.0K | · | $583.0K | |
| Total Assets | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Accounts Payable | $40M | $24M | $16M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $176M | $144M | $136M | $117M | $90M | $86M | $81M | $66M | $52M | $43M | · | $23M | $15M | $13M | · | $14M | |
| Capital Leases | $16M | $16M | $11M | $10M | $0 | $0 | · | $1M | $1M | $2M | · | $2M | $2M | · | · | $169.0K | |
| Other Non-current Liabilities | $16M | $16M | $11M | $10M | · | · | $0 | $1M | $1M | $2M | · | $2M | $2M | $40.0K | · | $209.0K | |
| Total Liabilities | $264M | $232M | $219M | $199M | $162M | $158M | $152M | $139M | $125M | $74M | · | $55M | $41M | $38M | · | $34M | |
| Long-term Debt | $73M | $73M | $72M | $72M | $72M | $72M | $72M | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Total Debt | $73M | $73M | · | $72M | $72M | $72M | · | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Paid-in Capital | $799M | $783M | $770M | $753M | $738M | $728M | $585M | $574M | $566M | $556M | · | $416M | $311M | $306M | · | $298M | |
| Retained Earnings | $-452M | $-434M | $-427M | $-418M | $-406M | $-385M | $-360M | $-337M | $-314M | $-280M | · | $-203M | $-164M | $-132M | · | $-95M | |
| AOCI | $-557.0K | $-298.0K | $381.0K | $289.0K | $39.0K | $85.0K | $179.0K | $346.0K | $-176.0K | $-63.0K | · | $-8.0K | $-23.0K | $-70.0K | · | $-10.0K | |
| Stockholders' Equity | $347M | $349M | $343M | $335M | $333M | $342M | $225M | $237M | $252M | $275M | $197M | $214M | $148M | $173M | $193M | $203M | |
| Liabilities + Equity | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Shares Outstanding | 43,271,347 | 43,021,312 | 42,553,931 | 42,447,882 | 42,210,972 | 41,995,537 | 38,349,826 | 38,196,072 | 38,030,385 | 37,749,468 | 34,211,190 | 33,104,087 | 26,899,572 | 26,800,512 | 26,727,458 | 26,671,812 |
Flux de trésorerie 13
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $14M | $12M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $200.0K | $240.0K | $321.0K | $200.0K | $200.0K | $240.0K | $240.0K | $100.0K | $100.0K | $100.0K | $133.0K | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $61M | $-25M | $19M | $18M | $-29M | $-21M | $-22M | $-9M | $-14M | $-38M | $-39M | $-32M | $-24M | $-22M | $-11M | $-19M | |
| CapEx | $4M | $6M | $6M | $2M | $1M | $590.0K | $72.0K | $282.0K | $1M | $174.0K | $0 | $375.0K | $787.0K | $340.0K | $127.0K | $96.0K | |
| Investing Cash Flow | $38M | $-59M | $49M | $-5M | $-52M | $-35M | $-60M | $3M | $-41M | $-102M | $18M | $47M | $64M | $11M | $-87M | $-57M | |
| Debt Issued | · | · | $0 | $0 | · | · | $0 | $0 | $75M | $0 | $0 | $5M | $0 | $5M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $5M | · | · | |
| Stock Issued | $0 | $0 | · | $0 | $-354.0K | $135M | · | $-43.0K | $-274.0K | $99M | · | $99M | $0 | $0 | · | $-218.0K | |
| Net Stock Activity | · | $0 | · | · | · | $135M | · | · | · | $99M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $1M | $2M | $3M | $2M | $137M | $3M | $639.0K | $42M | $109M | $20M | $105M | $510.0K | $5M | $264.0K | $-136.0K | |
| Net Change in Cash | $102M | $-82M | $71M | $16M | $-79M | $81M | $-79M | $-5M | $-13M | $-31M | $-2M | $120M | $41M | $-6M | $-98M | $-76M | |
| Taxes Paid | $3M | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-30M | · | · | · | $-21M | · | · | · | $-38M | · | · | · | $-22M | · | · |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| Net Margin | -10.7% | -4.3% | · | -10.6% | -19.8% | -32.1% | · | -48.7% | -81.6% | -129.4% | · | -2092.4% | · | · | · | · | |
| EBITDA Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| ROA | -3.4% | -1.3% | · | -2.8% | -4.7% | -5.9% | · | -7.3% | -11.8% | -12.8% | · | -15.5% | -14.2% | -11.9% | · | -10.5% | |
| ROE | -5.5% | -2.0% | · | -4.4% | -7.0% | -8.1% | · | -10.4% | -16.7% | -15.9% | · | -18.8% | -17.0% | -14.5% | · | -11.8% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | · | 4.3 | 5.3 | 5.6 | · | 5.4 | 7.0 | 8.0 | · | 11.2 | 12.4 | 15.7 | · | 16.4 | |
| Quick Ratio | 3.1 | 3.4 | · | 4.1 | 4.9 | 5.4 | · | 5.3 | 6.8 | 7.7 | · | 10.8 | 12.1 | 15.4 | · | 15.9 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.3 | · | -47.7 | -40.3 | -36.5 | · | -36.2 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | 2.9 | 2.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.3 | 2.0 | · | 2.3 | 2.3 | 1.7 | · | 2.8 | 2.8 | 1.7 | · | 0.7 | · | · | · | 0.0 |
Valorisation (TTM) 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $557M | $462M | · | $348M | $270M | $195M | · | $118M | $70M | $32M | · | $4M | $18M | $18M | · | $17M | |
| Net Income TTM | $-58M | $-65M | · | $-81M | $-102M | $-118M | · | $-132M | $-140M | $-130M | · | $-117M | $-83M | $-72M | · | $-64M | |
| Market Cap | $2.72B | $3.02B | · | $2.52B | $1.71B | $2.16B | · | $1.26B | $1.03B | $1.37B | · | $588M | $486M | $337M | · | $457M | |
| Enterprise Value | $2.35B | $2.70B | · | $2.19B | $1.40B | $1.82B | · | $1.01B | $782M | $1.10B | · | $371M | $332M | $160M | · | $249M | |
| P/E | -45.9 | -44.4 | · | -29.3 | -15.5 | -16.4 | · | -8.7 | -6.3 | -8.4 | · | -4.3 | -5.8 | -4.3 | · | -6.1 | |
| P/S | 4.9 | 6.5 | · | 7.3 | 6.3 | 11.1 | · | 10.6 | 14.7 | 42.9 | · | 134.6 | 27.3 | 18.4 | · | 26.8 | |
| P/B | 7.9 | 8.6 | · | 7.5 | 5.1 | 6.3 | · | 5.3 | 4.1 | 5.0 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Tangible Book | 8.0 | 8.8 | · | 7.7 | 5.3 | 6.5 | · | 5.5 | 4.2 | 5.1 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Cash Flow | · | -122.4 | · | · | · | -104.5 | · | · | · | -36.3 | · | · | · | -15.3 | · | · | |
| P / FCF | · | -99.0 | · | · | · | -101.6 | · | · | · | -36.1 | · | · | · | -15.1 | · | · | |
| EV / EBITDA | -117.9 | -441.3 | · | -150.9 | -63.2 | -69.3 | · | -40.2 | -23.5 | -29.3 | · | -9.1 | -10.1 | -6.4 | · | -10.9 | |
| EV / FCF | · | -88.7 | · | · | · | -85.7 | · | · | · | -29.1 | · | · | · | -7.2 | · | · | |
| EV / Revenue | 4.2 | 5.9 | · | 6.3 | 5.2 | 9.3 | · | 8.5 | 11.1 | 34.5 | · | 84.9 | 18.7 | 8.7 | · | 14.6 | |
| Earnings Yield | -2.2% | -2.2% | · | -3.4% | -6.4% | -6.1% | · | -11.5% | -16.0% | -11.9% | · | -23.5% | -17.3% | -23.4% | · | -16.5% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $451M | $183M | $17M | $26M | $57M |
| Marge d'exploitation % | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| Résultat net | $-66M | $-116M | $-136M | $-62M | $-14M |
| BPA dilué | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | 0.2 | 0.3 | 0.2 | 0.1 | — |
| Ratio de liquidité | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 |
| Ratio de liquidité réduite | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-22M | $-85M | $-119M | $-50M | $3M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 281 déclarants · $2.2B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 46 (-4 vs T. préc.) | 32 (+1 vs T. préc.) | 102 (+14 vs T. préc.) | 75 (+2 vs T. préc.) | +3.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| Deep Track Capital, LP | $230 786 378 | 3 666 768 | 10,62% | Actions |
| RTW INVESTMENTS, LP | $211 293 293 | 3 357 059 | 9,73% | Actions |
| Paradigm Biocapital Advisors LP | $174 699 348 | 2 775 649 | 8,04% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $112 855 448 | 1 793 064 | 5,19% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $98 706 662 | 1 568 266 | 4,54% | Actions |
| MILLENNIUM MANAGEMENT LLC | $89 823 185 | 1 427 124 | 4,13% | Actions |
| JENNISON ASSOCIATES LLC | $85 924 054 | 1 365 174 | 3,95% | Actions |
| STATE STREET CORP | $67 531 536 | 1 072 951 | 3,11% | Actions |
| Vestal Point Capital, LP | $66 087 000 | 1 050 000 | 3,04% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $60 171 216 | 955 795 | 2,77% | Actions |
| Assenagon Asset Management S.A. | $59 635 335 | 947 495 | 2,74% | Actions |
| BANK OF AMERICA CORP /DE/ | $57 474 227 | 913 159 | 2,65% | Actions |
| Frazier Life Sciences Management, L.P. | $45 860 853 | 728 644 | 2,11% | Actions |
| GOLDMAN SACHS GROUP INC | $39 934 864 | 634 491 | 1,84% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $38 222 000 | 607 272 | 1,76% | Actions |
| Clearbridge Investments, LLC | $34 578 420 | 549 387 | 1,59% | Actions |
| TORONTO DOMINION BANK | $32 115 324 | 510 253 | 1,48% | Actions |
| TimesSquare Capital Management, LLC | $27 259 589 | 388 590 | 1,25% | Actions |
| Caption Management, LLC | $25 805 400 | 410 000 | 1,19% | Option de vente |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $24 240 523 | 385 137 | 1,12% | Actions |
| FMR LLC | $22 739 718 | 361 292 | 1,05% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21 137 392 | 335 834 | 0,97% | Actions |
| Tri Locum Partners LP | $20 665 720 | 328 340 | 0,95% | Actions |
| MPM BIOIMPACT LLC | $20 267 121 | 322 007 | 0,93% | Actions |
| Driehaus Capital Management LLC | $19 988 233 | 317 576 | 0,92% | Actions |
| LOOMIS SAYLES & CO L P | $19 924 161 | 316 558 | 0,92% | Actions |
| Squarepoint Ops LLC | $18 619 163 | 295 824 | 0,86% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $18 019 030 | 286 289 | 0,83% | Actions |
| Artisan Partners Limited Partnership | $17 931 543 | 284 899 | 0,83% | Actions |
| D. E. Shaw & Co., Inc. | $17 770 605 | 282 342 | 0,82% | Actions |
| Rock Springs Capital Management LP | $17 439 856 | 277 087 | 0,80% | Actions |
| Ensign Peak Advisors, Inc | $16 911 726 | 268 696 | 0,78% | Actions |
| CITADEL ADVISORS LLC | $15 214 927 | 241 737 | 0,70% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $12 690 215 | 201 624 | 0,58% | Actions |
| MACKENZIE FINANCIAL CORP | $12 048 478 | 191 428 | 0,55% | Actions |
| JANE STREET GROUP, LLC | $11 964 894 | 190 100 | 0,55% | Option d'achat |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 864 190 | 188 500 | 0,55% | Option d'achat |
| Cutter Capital Management, LP | $10 530 850 | 205 000 | 0,48% | Actions |
| Parkman Healthcare Partners LLC | $9 441 000 | 150 000 | 0,43% | Actions |
| Seven Fleet Capital Management LP | $7 909 873 | 117 067 | 0,36% | Actions |
| Caption Management, LLC | $7 596 858 | 120 700 | 0,35% | Actions |
| Jefferies Financial Group Inc. | $7 477 901 | 118 810 | 0,34% | Actions |
| FIRST TRUST ADVISORS LP | $7 415 024 | 117 811 | 0,34% | Actions |
| Qube Research & Technologies Ltd | $7 323 887 | 116 363 | 0,34% | Actions |
| Woodline Partners LP | $6 321 882 | 100 443 | 0,29% | Actions |
| Cormorant Asset Management, LP | $6 294 000 | 100 000 | 0,29% | Actions |
| Schonfeld Strategic Advisors LLC | $6 284 243 | 99 845 | 0,29% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $6 224 766 | 98 900 | 0,29% | Actions |
| XTX Topco Ltd | $5 987 482 | 95 130 | 0,28% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $5 725 589 | 90 969 | 0,26% | Actions |
| HighVista Strategies LLC | $5 479 557 | 87 060 | 0,25% | Actions |
| Sands Capital Alternatives, LLC | $5 349 900 | 85 000 | 0,25% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $5 028 170 | 79 888 | 0,23% | Actions |
| JANUS HENDERSON GROUP PLC | $4 801 294 | 68 438 | 0,22% | Actions |
| Cubist Systematic Strategies, LLC | $4 395 129 | 73 955 | 0,20% | Actions |
| Freestone Grove Partners LP | $4 304 404 | 68 389 | 0,20% | Actions |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4 268 906 | 67 825 | 0,20% | Actions |
| CITIGROUP INC | $4 083 610 | 64 881 | 0,19% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $3 877 104 | 61 600 | 0,18% | Actions |
| Emerald Investment Advisers, LLC | $3 760 476 | 59 747 | 0,17% | Actions |
| Swiss National Bank | $3 759 595 | 59 733 | 0,17% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $3 756 322 | 59 681 | 0,17% | Actions |
| ALLIANCEBERNSTEIN L.P. | $3 579 684 | 51 029 | 0,16% | Actions |
| Eversept Partners, LP | $3 506 387 | 55 710 | 0,16% | Actions |
| Y-Intercept (Hong Kong) Ltd | $3 440 993 | 54 671 | 0,16% | Actions |
| BlackRock, Inc. | $3 375 850 | 53 636 | 0,16% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 375 850 | 53 636 | 0,16% | Actions |
| RHUMBLINE ADVISERS | $3 318 058 | 52 718 | 0,15% | Actions |
| TORONTO DOMINION BANK | $2 958 180 | 47 000 | 0,14% | Option d'achat |
| E. Ohman J:or Asset Management AB | $2 952 403 | 42 087 | 0,14% | Actions |
| Cinctive Capital Management LP | $2 906 695 | 46 182 | 0,13% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 832 300 | 45 000 | 0,13% | Option de vente |
| Trexquant Investment LP | $2 778 927 | 44 152 | 0,13% | Actions |
| Voleon Capital Management LP | $2 731 911 | 43 405 | 0,13% | Actions |
| ALPS ADVISORS INC | $2 729 393 | 43 365 | 0,13% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 644 304 | 37 695 | 0,12% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $2 628 311 | 41 759 | 0,12% | Actions |
| Odyssean, LLC | $2 605 338 | 41 394 | 0,12% | Actions |
| PFM Health Sciences, LP | $2 554 042 | 40 579 | 0,12% | Actions |
| Vontobel Holding Ltd. | $2 517 600 | 40 000 | 0,12% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $2 473 731 | 39 303 | 0,11% | Actions |
| Baird Financial Group, Inc. | $2 448 240 | 38 898 | 0,11% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 404 182 | 38 198 | 0,11% | Actions |
| TWO SIGMA INVESTMENTS, LP | $2 268 232 | 36 038 | 0,10% | Actions |
| ORBIMED ADVISORS LLC | $2 239 468 | 35 581 | 0,10% | Actions |
| BARCLAYS PLC | $2 212 088 | 35 146 | 0,10% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 095 273 | 33 290 | 0,10% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $2 071 230 | 32 908 | 0,10% | Actions |
| PDT Partners, LLC | $2 032 458 | 32 292 | 0,09% | Actions |
| Ikarian Capital, LLC | $1 961 588 | 31 166 | 0,09% | Actions |
| MILLENNIUM MANAGEMENT LLC | $1 888 200 | 30 000 | 0,09% | Option d'achat |
| OCCUDO QUANTITATIVE STRATEGIES LP | $1 866 737 | 29 659 | 0,09% | Actions |
| VANGUARD GROUP INC | $1 698 846 | 20 748 | 0,08% | Actions |
| J. Goldman & Co LP | $1 686 792 | 26 800 | 0,08% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1 654 755 | 26 291 | 0,08% | Actions |
| AlphaQuest LLC | $1 571 523 | 19 193 | 0,07% | Actions |
| Entropy Technologies, LP | $1 547 254 | 24 583 | 0,07% | Actions |
| MetLife Investment Management, LLC | $1 541 589 | 24 493 | 0,07% | Actions |
| Lido Advisors, LLC | $1 530 827 | 24 322 | 0,07% | Actions |
| Atika Capital Management LLC | $1 468 642 | 23 334 | 0,07% | Actions |
Initiés de la société 21 initiés · 9 dirigeants · 12 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Bobak R. Azamian | President/CEO and Board Chair | 17 juin 2026 S | 847 991 | 0 | 2 | $-615 489 |
| Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | 15 juin 2026 M | 56 801 | 0 | 4 | $-1 317 002 |
| Leonard M. Greenstein | Chief Financial Officer | 8 mars 2023 A | — | 0 | 0 | $0 |
| Seshadri Neervannan | Chief Operating Officer | 15 mars 2023 M | 56 577 | 0 | 0 | $0 |
| Aziz Mottiwala | Chief Commercial Officer | 8 juin 2023 S | 48 086 | 0 | 0 | $0 |
| Bryan Wahl | General Counsel | 15 mars 2023 M | 18 176 | 0 | 0 | $0 |
| Dianne C. Whitfield | Chief Human Resources Officer | 15 mars 2023 M | 12 872 | 0 | 0 | $0 |
| Mark J. Holdbrook | V.P., Clinical Affairs | 15 mars 2023 M | 3 577 | 0 | 0 | $0 |
| Jose M. Trevejo | Chief Medical Officer | 15 mars 2023 M | 8 654 | 0 | 0 | $0 |
| Katherine Goodrich | Administrateur | 25 juin 2026 A | 2 233 | 0 | 1 | $-183 384 |
| Andrew D. Goldberg | Administrateur | 25 juin 2026 A | 19 654 | 0 | 0 | $0 |
| Scott W Morrison | Administrateur | 25 juin 2026 A | 7 638 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Administrateur | 25 juin 2026 A | 11 654 | 0 | 0 | $0 |
| William J Link PHD | Administrateur | 25 juin 2026 A | 106 786 | 0 | 10 | $-3 500 993 |
| Wendy L Yarno | Administrateur | 25 juin 2026 A | 16 654 | 0 | 0 | $0 |
| David E I Pyott | Administrateur | 25 juin 2026 A | 1 383 | 0 | 0 | $0 |
| Michael Ackermann | Administrateur | 15 juin 2022 M | 1 208 273 | 0 | 0 | $0 |
| Elizabeth Yeu Lin | Administrateur | 31 décembre 2021 A | — | 0 | 0 | $0 |
| Rosemary A Crane | Administrateur | 11 août 2021 A | — | 0 | 0 | $0 |
| Jason E. Tester | Administrateur | 15 juin 2021 A | 1 920 933 | 0 | 0 | $0 |
| Horowitz Limited Partnership VIII | Détenteur de 10% | 20 octobre 2020 C | 66 172 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Horowitz Limited Partnership VIII, Horowitz Management, Inc., Adam S. Horowitz Revocable Trust, Jason E. Tester | 30 octobre 2020 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 50 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,69% | 210 454 SH | 8 août 2026 | Quotidien |
| SBIO · ALPS ETF Trust | 1,61% | 43 870 NS | 31 mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,25% | 11 632 NS | 30 avril 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,22% | 2 469 NS | 30 avril 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,19% | 29 463 NS | 30 avril 2026 | N-PORT |
| IHE · iShares Trust | 0,57% | 141 498 SH | 8 août 2026 | Quotidien |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,40% | 66 585 NS | 30 avril 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,24% | 3 915 NS | 31 mai 2026 | N-PORT |
| IBB · iShares Trust | 0,20% | 295 665 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 2 342 SH | 8 août 2026 | Quotidien |
| ESSC · Strategy Shares | 0,18% | 712 NS | 30 avril 2026 | N-PORT |
| IWO · iShares Trust | 0,17% | 379 742 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 44 912 SH | 8 août 2026 | Quotidien |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,16% | 29 611 NS | 30 avril 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,13% | 1 124 NS | 31 mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 1 573 NS | 31 mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,12% | 19 431 NS | 31 mai 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 40 784 NS | 30 avril 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1 305 NS | 30 avril 2026 | N-PORT |
| SMLF · iShares Trust | 0,10% | 65 431 SH | 8 août 2026 | Quotidien |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 11 160 NS | 30 avril 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 1 067 848 SH | 8 août 2026 | Quotidien |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 6 209 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 241 028 SH | 8 août 2026 | Quotidien |
| ISCG · iShares Trust | 0,08% | 12 043 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,08% | 17 152 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 1 862 NS | 31 mai 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 21 718 SH | 8 août 2026 | Quotidien |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 187 238 NS | 31 mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1 688 SH | 8 août 2026 | Quotidien |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 1 565 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,03% | 1 456 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 14 864 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 455 389 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,03% | 89 651 SH | 8 août 2026 | Quotidien |
| URTY · ProShares Trust | 0,02% | 1 476 NS | 31 mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 9 169 SH | 8 août 2026 | Quotidien |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 6 187 SH | 8 août 2026 | Quotidien |
| WSML · iShares Trust | 0,02% | 1 892 SH | 8 août 2026 | Quotidien |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 590 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 37 NS | 31 mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 13 644 NS | 31 mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 54 981 SH | 8 août 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 9 881 SH | 8 août 2026 | Quotidien |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 23 482 NS | 31 mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30 avril 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 18 NS | 31 mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 295 901 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 359 SH | 8 août 2026 | Quotidien |
| FTLS · First Trust Exchange-Traded Fund III | -0,03% | -12 099 NS | 30 avril 2026 | N-PORT |